Cargando…
Insights Into the Function and Clinical Application of HDAC5 in Cancer Management
Histone deacetylase 5 (HDAC5) is a class II HDAC. Aberrant expression of HDAC5 has been observed in multiple cancer types, and its functions in cell proliferation and invasion, the immune response, and maintenance of stemness have been widely studied. HDAC5 is considered as a reliable therapeutic ta...
Autores principales: | Yang, Jun, Gong, Chaoju, Ke, Qinjian, Fang, Zejun, Chen, Xiaowen, Ye, Ming, Xu, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222663/ https://www.ncbi.nlm.nih.gov/pubmed/34178647 http://dx.doi.org/10.3389/fonc.2021.661620 |
Ejemplares similares
-
Lipid metabolic features of T cells in the Tumor Microenvironment
por: Lou, Wanshuang, et al.
Publicado: (2022) -
HDAC-an important target for improving tumor radiotherapy resistance
por: Ling, Rui, et al.
Publicado: (2023) -
Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy
por: Wu, Donglu, et al.
Publicado: (2020) -
The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib
por: Booth, Laurence, et al.
Publicado: (2019) -
Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma
por: Zhong, Mengya, et al.
Publicado: (2021)